ClinicalTrials.Veeva

Menu

Cigarette Smoking Decision Study

Johns Hopkins University logo

Johns Hopkins University

Status

Completed

Conditions

Tobacco Smoking

Treatments

Behavioral: Smoking sessions

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04595279
R01DA049814 (U.S. NIH Grant/Contract)
IRB00264306

Details and patient eligibility

About

The Family Smoking Prevention and Tobacco Control Act granted the FDA the authority to regulate and restrict tobacco advertising tactics that inaccurately convey reduced product risk, yet there is a dearth of up-to-date regulatory science to inform such regulations. Although the FDA has restricted use of descriptors such as "natural" and "additive-free," research shows that the tobacco industry quickly pivoted to increase use of alternative, unregulated tactics. Greenwashing is one increasingly common tobacco marketing strategy in which products are portrayed as eco-friendly and/or natural. The investigators' preliminary research indicates that greenwashing tactics may inaccurately convey modified product risk to consumers. The overarching objective of this project is to test the effect of greenwashing methods used by cigarette companies to market products on actual smoking behavior in a controlled laboratory study. The investigators' proposed research focuses on young adults (age 18-29), because this is a key age for smoking initiation and escalation, and research has found that young adults may be more susceptible than older adults to greenwashing in cigarette ads. This study will test the effect of greenwashing on behavioral economic demand and smoking topography in a laboratory-controlled cigarette self-administration study. These data will clearly connect tobacco advertising features to product risk perceptions and actual smoking behavior. This work will provide FDA with an integrated set of evidence that identifies misleading greenwashing tactics that inaccurately convey modified product risk which can be used to inform regulatory action regarding restrictions of this type of advertising.

Enrollment

37 patients

Sex

All

Ages

18 to 29 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18 - 29 years of age
  • Smoke at least five cigarettes per day
  • Have an expired carbon monoxide level of more than 8 ppm or a urinary cotinine level of more than 100 ng per milliliter

Exclusion criteria

  • The intention to quit smoking in the next 30 days
  • Report "roll your own" cigarettes as an exclusive form of smoking
  • A serious medical or psychiatric disorder or unstable condition
  • Any positive toxicological screening for illicit drugs other than cannabis will be excluded
  • Women who are pregnant, plan to become pregnant or are breast-feeding

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

37 participants in 1 patient group

Smoking sessions
Experimental group
Description:
This is the single arm that will go through cigarette smoking sessions
Treatment:
Behavioral: Smoking sessions

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Justin Strickland, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems